Surgical Evaluation for Upper Extremity Lymphedema (BioBridge)
Part of paid clinical trials in Stanford, California.
- Sponsor
- Fibralign Corporation
- Study ID
- NCT05695924
- Status
- Recruiting
Conditions
- Edema
- Lymphedema
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 75 Years
- Healthy Volunteers
- Not accepted
Interventions
- BioBridge® Collagen Matrix — DEVICEBioBridge Collagen Matrix (BioBridge) is a sterile implantable bio-compatible and biodegradable surgical mesh ribbon comprised of highly purified porcine collagen. The Class II device was cleared by CDRH Division of Surgical Devices on 8 January 2016 under 510(k) K151083. The device will be used for soft tissue surgical support at the time of vascularized lymph node transplant surgery (VLNT); the device will be used, specifically, for surgical support of the lymphatic component of the soft tissue.
- Vascularized Lymph Node Transfer (VLNT) — PROCEDUREMicro-surgical procedure for vascularized lymph node transfer (VLNT)
Study Details
To investigate whether the addition of Fibralign's BioBridge® Collagen Matrix (BioBridge) devices to the standard surgery for vascularized lymph node transfer will improve the outcome of surgical treatment in lymphedema of the upper arm.
Key Dates
- Start date
- Nov 1, 2023
- Status verified
- Mar 2025
- Primary completion
- Oct 1, 2025
- Completion
- Dec 1, 2025
Study Design
- Enrollment
- 60 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: BioBridge treatment groupVascularized Lymph Node Transplant surgery (VLNT) supplemented by BioBridge Collagen Matrix implantation
- Active Comparator: Control groupVascularized Lymph Node Transplant surgery (VLNT) only
Primary Outcome Measure
Excess limb volume change [ Time Frame: Baseline and 12 months after treatment ]
Central Contacts
- Shannon Meyer650-721-1807
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Stanford University | Stanford | California | 94305 | Dung H Nguyen, MD, PharmD |
Find similar trials in Stanford, CA
By research site
Related Studies
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Phoenix, Arizona
- A Non-randomized, Open-Label Study to Evaluate the Safety and Effectiveness of the Dayspring Technology for Patients With Breast Cancer Related Lymphedema (BCRL) After Lymphatic SurgeryRecruiting · Koya Medical, Inc. · Palo Alto, California
- LYMPHA Procedure for the Prevention of Lymphedema After Axillary LymphadenectomyRecruiting · Stanford University · San Francisco, California
- Evaluating Factors In Study Experiences of Lymphedema PatientsNot Yet Recruiting · Power Life Sciences Inc. · San Francisco, California